Healthequity, Inc. income statement

In fiscal 2026, Healthequity, Inc. reported revenue of $1.31bn, up 9.5% on the year before, operating income of $322m (a 24.6% margin) and net income of $215m, or $2.46 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Healthequity, Inc.: income statement, annual
Fiscal year	2013Jan 2013	2014Jan 2014	2015Jan 2015	2016Jan 2016	2017Jan 2017	2018Jan 2018	2019Jan 2019	2020Jan 2020	2021Jan 2021	2022Jan 2022	2023Jan 2023	2024Jan 2024	2025Jan 2025	2026Jan 2026	LTMJul 2026
Revenue	46	62	88	127	178	230	287	532	734	757	862	1,000	1,200	1,313	1,362
Cost of revenue	—	—	—	—	72	95	106	206	318	332	370	377	423	400	392
Gross profit	24	33	48	73	106	135	181	326	415	425	492	623	777	913	970
Research and development	4	7	11	17	22	27	35	78	125	157	193	219	240	263	278
Selling and marketing	8	9	11	13	18	23	29	44	50	59	69	79	91	95	99
General and administrative	3	4	8	14	20	25	33	61	84	85	97	104	132	120	130
Operating income	7	12	17	26	41	54	78	77	34	−24	9	118	162	322	351
Interest expense	0	0	0	—	—	0	0	25	35	37	48	55	61	57	53
Income before tax	7	5	16	26	40	52	76	43	4	−67	−38	75	116	277	309
Income tax	−5	4	6	9	14	5	2	3	−5	−22	−12	19	19	62	72
Net income	11	1	10	17	26	47	74	40	9	−44	−26	56	97	215	236
Diluted EPS	$0.25	−$1.26	$0.21	$0.28	$0.44	$0.77	$1.17	$0.58	$0.12	−$0.53	−$0.31	$0.64	$1.09	$2.46	$2.76
Diluted shares (average)	38m	6m	52m	59m	60m	62m	63m	68m	76m	83m	84m	87m	89m	87m	86m
EBITDA	10	16	23	35	54	70	96	132	150	113	170	271	325	477	429

US$ millions unless shown otherwise. Fiscal quarters.

Healthequity, Inc.: income statement, quarterly
Quarter	2025 Q3Oct 2024	2025 Q4Jan 2025	2026 Q1Apr 2025	2026 Q2Jul 2025	2026 Q3Oct 2025	2026 Q4Jan 2026	2027 Q1Apr 2026	2027 Q2Jul 2026
Revenue	300	312	331	326	322	335	355	351
Cost of revenue	103	123	107	93	94	106	98	93
Gross profit	197	189	224	233	228	228	256	258
Research and development	60	65	61	65	66	70	68	74
Selling and marketing	23	23	26	20	24	25	27	23
General and administrative	32	30	26	30	31	34	31	35
Operating income	20	42	83	90	79	71	103	99
Interest expense	18	15	15	15	14	13	13	13
Income before tax	6	30	71	78	68	61	92	88
Income tax	1	4	17	18	16	11	23	22
Net income	6	26	54	60	52	50	69	66
Diluted EPS	$0.06	$0.30	$0.61	$0.68	$0.59	$0.58	$0.82	$0.78
EBITDA	21	81	122	90	79	110	141	99

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HQY vs PGNY ADUS vs HQY HQY vs PIII GH vs HQY

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Healthequity, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Healthequity, Inc.